rs1555764839
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001083962.2(TCF4):c.1169delT(p.Leu390fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L390L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001083962.2 frameshift
Scores
Clinical Significance
Conservation
Publications
- Pitt-Hopkins syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, ClinGen
- corneal dystrophy, Fuchs endothelial, 3Inheritance: AD Classification: STRONG Submitted by: G2P
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fuchs' endothelial dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autism spectrum disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001083962.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCF4 | NM_001083962.2 | MANE Select | c.1169delT | p.Leu390fs | frameshift | Exon 15 of 20 | NP_001077431.1 | ||
| TCF4 | NM_001243226.3 | c.1475delT | p.Leu492fs | frameshift | Exon 16 of 21 | NP_001230155.2 | |||
| TCF4 | NM_001243228.2 | c.1187delT | p.Leu396fs | frameshift | Exon 15 of 20 | NP_001230157.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCF4 | ENST00000354452.8 | TSL:5 MANE Select | c.1169delT | p.Leu390fs | frameshift | Exon 15 of 20 | ENSP00000346440.3 | ||
| TCF4 | ENST00000398339.5 | TSL:1 | c.1475delT | p.Leu492fs | frameshift | Exon 16 of 21 | ENSP00000381382.1 | ||
| TCF4 | ENST00000356073.8 | TSL:1 | c.1169delT | p.Leu390fs | frameshift | Exon 15 of 20 | ENSP00000348374.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pitt-Hopkins syndrome Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in TCF4 are known to be pathogenic (PMID: 18728071, 22045651). This variant has not been reported in the literature in individuals with TCF4-related conditions. ClinVar contains an entry for this variant (Variation ID: 547794). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu390*) in the TCF4 gene. It is expected to result in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at